| Dr Nana Abena Arthur, MD | |
|
8954 Hosptial Drive, Wellstar Health System Douglas Hospital, Douglasville, GA 30134 | |
| (678) 838-2585 | |
| Not Available |
| Full Name | Dr Nana Abena Arthur |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 24 Years |
| Location | 8954 Hosptial Drive, Douglasville, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144382706 | NPI | - | NPPES |
| 059117 | Other | GA | PHYSICIAN LICENSE |
| 044538 | Other | CT | PHYSICIAN LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 059117 (Georgia) | Secondary |
| 208M00000X | Hospitalist | 059117 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellstar Douglas Hospital | Douglasville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellstar Medical Group, Llc | 6709065402 | 1839 |
News Archive
Researchers have successfully treated age-related macular degeneration in mice after finding an unexpected link between the two main forms of the blinding eye disease, the leading cause of vision loss in people 60 and older.
Wilson Therapeutics AB, a privately-held biopharmaceutical company, today announced its sponsorship of the first annual Big Walk on Wilson's (BIG WOW). The event will take place on September 19, 2015 in sixteen cities across North America to increase awareness of Wilson's Disease and raise funds for the Wilson Disease Association.
Two new studies published in the April 4 online issue of Neurology, the medical journal of the American Academy of Neurology, suggest that a person's memory declines at a faster rate in the last two-and-a-half years of life than at any other time after memory problems first begin. The second study shows that keeping mentally fit through board games or reading may be the best way to preserve memory during late life.
Doctors from around the UK are taking part in one of the world's largest lung cancer clinical trials investigating how a blood thinning drug might help prevent blood clots in lung cancer patients.
Semafore Pharmaceuticals today announced today announced the United States Patent and Trademark Office (PTO) has issued United States Patent Number 7,662,977 entitled "PI-3 Kinase Inhibitor Prodrugs." This composition of matter patent covers a genus of novel compounds that includes SF1126, Semafore's clinical stage, small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K signaling pathway that is vital to several essential biological processes, such as cell proliferation and survival.
› Verified 3 days ago
| Entity Name | Wellstar Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
Researchers have successfully treated age-related macular degeneration in mice after finding an unexpected link between the two main forms of the blinding eye disease, the leading cause of vision loss in people 60 and older.
Wilson Therapeutics AB, a privately-held biopharmaceutical company, today announced its sponsorship of the first annual Big Walk on Wilson's (BIG WOW). The event will take place on September 19, 2015 in sixteen cities across North America to increase awareness of Wilson's Disease and raise funds for the Wilson Disease Association.
Two new studies published in the April 4 online issue of Neurology, the medical journal of the American Academy of Neurology, suggest that a person's memory declines at a faster rate in the last two-and-a-half years of life than at any other time after memory problems first begin. The second study shows that keeping mentally fit through board games or reading may be the best way to preserve memory during late life.
Doctors from around the UK are taking part in one of the world's largest lung cancer clinical trials investigating how a blood thinning drug might help prevent blood clots in lung cancer patients.
Semafore Pharmaceuticals today announced today announced the United States Patent and Trademark Office (PTO) has issued United States Patent Number 7,662,977 entitled "PI-3 Kinase Inhibitor Prodrugs." This composition of matter patent covers a genus of novel compounds that includes SF1126, Semafore's clinical stage, small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K signaling pathway that is vital to several essential biological processes, such as cell proliferation and survival.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nana Abena Arthur, MD 8954 Hospital Dr, Douglasville, GA 30134-2272 Ph: (678) 838-2585 | Dr Nana Abena Arthur, MD 8954 Hosptial Drive, Wellstar Health System Douglas Hospital, Douglasville, GA 30134 Ph: (678) 838-2585 |
News Archive
Researchers have successfully treated age-related macular degeneration in mice after finding an unexpected link between the two main forms of the blinding eye disease, the leading cause of vision loss in people 60 and older.
Wilson Therapeutics AB, a privately-held biopharmaceutical company, today announced its sponsorship of the first annual Big Walk on Wilson's (BIG WOW). The event will take place on September 19, 2015 in sixteen cities across North America to increase awareness of Wilson's Disease and raise funds for the Wilson Disease Association.
Two new studies published in the April 4 online issue of Neurology, the medical journal of the American Academy of Neurology, suggest that a person's memory declines at a faster rate in the last two-and-a-half years of life than at any other time after memory problems first begin. The second study shows that keeping mentally fit through board games or reading may be the best way to preserve memory during late life.
Doctors from around the UK are taking part in one of the world's largest lung cancer clinical trials investigating how a blood thinning drug might help prevent blood clots in lung cancer patients.
Semafore Pharmaceuticals today announced today announced the United States Patent and Trademark Office (PTO) has issued United States Patent Number 7,662,977 entitled "PI-3 Kinase Inhibitor Prodrugs." This composition of matter patent covers a genus of novel compounds that includes SF1126, Semafore's clinical stage, small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K signaling pathway that is vital to several essential biological processes, such as cell proliferation and survival.
› Verified 3 days ago
Dr. Rashmi Sharma, M.B.B.S Hospitalist Medicare: Medicare Enrolled Practice Location: 8820 Hospital Dr, Douglasville, GA 30134 Phone: 770-947-3000 | |
Alsadek Sultan, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8954 Hospital Drive, Douglas Hospitalist, Douglasville, GA 30314 Phone: 678-838-2585 | |
Nasira Hussain, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8954 Hospital Drive, Douglasville, GA 30134 Phone: 678-838-2585 | |
Rafiq M. El Hammali, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6095 Professional Pkwy, Suite B205, Douglasville, GA 30134 Phone: 770-577-4825 Fax: 770-577-4827 |